Retractable Technologies (NYSE:RVP) Receives New Coverage from Analysts at StockNews.com

StockNews.com assumed coverage on shares of Retractable Technologies (NYSE:RVPFree Report) in a research note issued to investors on Wednesday morning. The brokerage issued a hold rating on the stock.

Retractable Technologies Stock Performance

RVP opened at $1.03 on Wednesday. The stock’s 50 day moving average price is $1.21 and its two-hundred day moving average price is $1.16. The company has a quick ratio of 6.41, a current ratio of 8.28 and a debt-to-equity ratio of 0.01. Retractable Technologies has a 12-month low of $0.95 and a 12-month high of $1.90.

Institutional Trading of Retractable Technologies

Hedge funds have recently modified their holdings of the company. Vanguard Group Inc. grew its stake in shares of Retractable Technologies by 12.6% in the 1st quarter. Vanguard Group Inc. now owns 1,092,079 shares of the company’s stock valued at $5,188,000 after purchasing an additional 122,231 shares during the period. NewEdge Advisors LLC acquired a new stake in shares of Retractable Technologies during the 1st quarter worth about $77,000. State Street Corp increased its position in shares of Retractable Technologies by 1.2% during the 1st quarter. State Street Corp now owns 304,431 shares of the company’s stock worth $1,446,000 after purchasing an additional 3,730 shares in the last quarter. Royal Bank of Canada increased its position in shares of Retractable Technologies by 29.7% during the 1st quarter. Royal Bank of Canada now owns 13,265 shares of the company’s stock worth $63,000 after purchasing an additional 3,037 shares in the last quarter. Finally, FMR LLC increased its position in shares of Retractable Technologies by 190.0% during the 2nd quarter. FMR LLC now owns 16,216 shares of the company’s stock worth $62,000 after purchasing an additional 10,625 shares in the last quarter. Institutional investors own 7.58% of the company’s stock.

About Retractable Technologies

(Get Free Report)

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.

Recommended Stories

Receive News & Ratings for Retractable Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Retractable Technologies and related companies with MarketBeat.com's FREE daily email newsletter.